
Pfizer sees all-time high for 2022 revenues; but declining COVID-19 products market will hit 2023 sales
Pfizer expects to see a 64% drop in Comirnaty revenues this year, which will hit its 2023 revenue guidance.
Pfizer expects to see a 64% drop in Comirnaty revenues this year, which will hit its 2023 revenue guidance.